Revised disclosure under Reg 30 for resignation of Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 4.7 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Two board members — Mr. Deep Ashda Lalvani (Whole Time Director and CFO) and Ms. Tanya Halina Advani (Non-Executive Director) — have resigned from the company with effect from 27th May 2025. The resignations are linked to a change in control of the company following a Share Purchase Agreement signed on 21st March 2025 between the existing promoters and new acquirers (the 'Takeover'). Both directors cited the management and ownership transition as the reason and confirmed they have no outstanding claims against the company. This is a resubmitted disclosure sent on 10th June 2025 to correct a clerical file-merging error in the original 27th May filing. No new directors have been named in this disclosure.
The exit of the CFO and a director is a direct consequence of the takeover, so existing shareholders should expect a broader board reshuffle as new acquirers install their own leadership. The company remains compliant with disclosure norms but faces a short transition period at the finance and board level.